ACTIVE (Ability Captured Through Interactive Video Evaluation) workspace volume video game to quantify meaningful change in spinal muscular atrophy

被引:12
作者
Alfano, Lindsay N. [1 ]
Miller, Natalie F. [1 ]
Iammarino, Megan A. [1 ]
Moore Clingenpeel, Melissa [2 ]
Lowes, Suzanne L. [3 ]
Dugan, Margaret E. [1 ]
Kissel, John T. [4 ]
Al Zaidy, Samiah [1 ,5 ]
Tsao, Chang-Yong [5 ]
Lowes, Linda P. [1 ,5 ]
机构
[1] Nationwide Childrens Hosp, Ctr Gene Therapy, Columbus, OH USA
[2] Nationwide Childrens Hosp, Res Inst, Biostat Core, Columbus, OH USA
[3] Univ Dayton, Dayton, OH 45469 USA
[4] Ohio State Univ, Coll Med, Dept Neurol, Columbus, OH 43210 USA
[5] Ohio State Univ, Dept Pediat, Coll Med, Columbus, OH 43210 USA
关键词
FUNCTIONAL MOTOR SCALE; RESPONSIVENESS; VALIDITY;
D O I
10.1111/dmcn.14230
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Aim To evaluate the utility of Ability Captured Through Interactive Video Evaluation (ACTIVE) scaled scores to quantify meaningful change in individuals with spinal muscular atrophy (SMA) types 2 or 3 due to disease progression or treatment. Method ACTIVE is a custom-designed video game that measures workspace volume (WSV). Participants included 62 individuals with SMA (mean age [SD] 10y 9mo [5y], range 2y 9mo-24y) and 362 frequency-matched controls (mean age [SD] 10y 9mo [3y 6mo], range 3y 2mo-24y 9mo). Participants completed ACTIVE, other traditional assessments, and patient-reported outcomes. Responsiveness to change was evaluated by comparing longitudinal data on untreated participants to those receiving Spinraza. Results ACTIVE was significantly correlated to the Hammersmith Functional Motor Scales Expanded and Revised Upper Limb Module (rho=0.85 and rho=0.92 respectively; p<0.001). Relevance to patients and families was established by strong correlations to the Patient Reported Outcomes Measurement Information System self- and parent proxy-measures of upper extremity ability (rho=0.63 and rho=0.70 respectively; p<0.001). Responsiveness to change was demonstrated by significant change in scaled scores after treatment (median 15.9 points, Wilcoxon signed-rank test p<0.01). A preliminary minimum clinically important difference is presented. Interpretation These results suggest that ACTIVE WSV scores are a meaningful assessment with which to quantify change over time in individuals with SMA types 2 and 3. What this paper adds Ability Captured Through Interactive Video Evaluation (ACTIVE) quantifies upper extremity function in spinal muscular atrophy. ACTIVE's scaled workspace volume strongly correlates to self- and parent-report of function. ACTIVE quantifies meaningful change after treatment.
引用
收藏
页码:303 / +
页数:8
相关论文
共 27 条
[1]   Developing the Patient-Reported Outcomes Measurement Information System (PROMIS) [J].
Ader, Deborah N. .
MEDICAL CARE, 2007, 45 (05) :S1-S2
[2]  
[Anonymous], SPINRAZA
[3]  
[Anonymous], PLOS CURR
[4]   DUCHENNE MUSCULAR-DYSTROPHY - PATTERNS OF CLINICAL PROGRESSION AND EFFECTS OF SUPPORTIVE THERAPY [J].
BROOKE, MH ;
FENICHEL, GM ;
GRIGGS, RC ;
MENDELL, JR ;
MOXLEY, R ;
FLORENCE, J ;
KING, WM ;
PANDYA, S ;
ROBISON, J ;
SCHIERBECKER, J ;
SIGNORE, L ;
MILLER, JP ;
GILDER, BF ;
KAISER, KK ;
MANDEL, S ;
ARFKEN, C .
NEUROLOGY, 1989, 39 (04) :475-481
[5]   RASCH ANALYSIS OF CLINICAL OUTCOME MEASURES IN SPINAL MUSCULAR ATROPHY [J].
Cano, Stefan J. ;
Mayhew, Anna ;
Glanzman, Allan M. ;
Krosschell, Kristin J. ;
Swoboda, Kathryn J. ;
Main, Marion ;
Steffensen, Birgit F. ;
Berard, Carole ;
Girardot, Francoise ;
Payan, Christine A. M. ;
Mercuri, Eugenio ;
Mazzone, Elena ;
Elsheikh, Bakri ;
Florence, Julaine ;
Hynan, Linda S. ;
Iannaccone, Susan T. ;
Nelson, Leslie L. ;
Pandya, Shree ;
Rose, Michael ;
Scott, Charles ;
Sadjadi, Reza ;
Yore, Mackensie A. ;
Joyce, Cynthia ;
Kissel, John T. .
MUSCLE & NERVE, 2014, 49 (03) :422-430
[6]   The Patient-Reported Outcomes Measurement Information System (PROMIS) Progress of an NIH roadmap cooperative group during its first two years [J].
Cella, David ;
Yount, Susan ;
Rothrock, Nan ;
Gershon, Richard ;
Cook, Karon ;
Reeve, Bryce ;
Ader, Deborah ;
Fries, James F. ;
Bruce, Bonnie ;
Rose, Mattias .
MEDICAL CARE, 2007, 45 (05) :S3-S11
[7]   Defining clinically meaningful change in health-related quality of life [J].
Crosby, RD ;
Kolotkin, RL ;
Williams, GR .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2003, 56 (05) :395-407
[8]   Emerging Therapies and Challenges in Spinal Muscular Atrophy [J].
Farrar, Michelle A. ;
Park, Susanna B. ;
Vucic, Steve ;
Carey, Kate A. ;
Turner, Bradley J. ;
Gillingwater, Thomas H. ;
Swoboda, Kathryn J. ;
Kiernan, Matthew C. .
ANNALS OF NEUROLOGY, 2017, 81 (03) :355-368
[9]   Nusinersen treatment of spinal muscular atrophy: current knowledge and existing gaps [J].
Gidaro, Teresa ;
Servais, Laurent .
DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2019, 61 (01) :19-+
[10]  
Glanzman Allan M, 2018, J Neuromuscul Dis, V5, P159, DOI 10.3233/JND-180301